Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven E Feldon

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Thyroid : Official Journal of the American Thyroid Association|July 25, 2008
Improvement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxibAjay E Kuriyan, Richard P Phipps, Charles W O'Loughlin, et al.
Thyroid : Official Journal of the American Thyroid Association|August 30, 2008
Immune mechanisms in thyroid eye diseaseGeniece M Lehmann, Steven E Feldon, Terry J Smith, et al.
Frontiers in Toxicology|March 17, 2022
More than Meets the Eye: The Aryl Hydrocarbon Receptor is an Environmental Sensor, Physiological Regulator and a Therapeutic Target in Ocular DiseaseChristine L Hammond, Elisa Roztocil, Vardaan Gupta, et al.
Investigative Ophthalmology & Visual Science|January 31, 2003
Sweep visual evoked potential evaluation of contrast sensitivity in Alzheimer's dementiaRobert W Crow, Lori B Levin, Laurie LaBree, et al.
Investigative Ophthalmology & Visual Science|November 19, 2024
Tapinarof, an Aryl Hydrocarbon Receptor Ligand, Mitigates Fibroblast Activation in Thyroid Eye Disease: Implications for Novel TherapyCharkira C Patrick, Elisa Roztocil, Farha Husain, et al.
Experimental Eye Research|March 23, 2026
Metformin inhibits PDGFβ signaling to suppress hyaluronan and cytokine production in thyroid eye diseaseFarha Husain, Charkira C Patrick, Elisa Roztocil, et al.
Thyroid : Official Journal of the American Thyroid Association|April 21, 2025
Targeting the Aryl Hydrocarbon Receptor to Attenuate IGF1R Signaling in Thyroid Eye DiseaseElisa Roztocil, Farha Husain, Charkira C Patrick, et al.
Investigative Ophthalmology & Visual Science|September 4, 2015
Retinal and Choroidal Folds in PapilledemaPatrick A Sibony, Mark J Kupersmith, Steven E Feldon, et al.
The Journal of Biological Chemistry|December 25, 2014
Salinomycin and other polyether ionophores are a new class of antiscarring agentCollynn F Woeller, Charles W O'Loughlin, Elisa Roztocil, et al.
Plos One|September 20, 2019
Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptorChristine L Hammond, Elisa Roztocil, Richard P Phipps, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Thyroid : Official Journal of the American Thyroid Association|July 25, 2008
Improvement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxibAjay E Kuriyan, Richard P Phipps, Charles W O'Loughlin, et al.
Thyroid : Official Journal of the American Thyroid Association|August 30, 2008
Immune mechanisms in thyroid eye diseaseGeniece M Lehmann, Steven E Feldon, Terry J Smith, et al.
Frontiers in Toxicology|March 17, 2022
More than Meets the Eye: The Aryl Hydrocarbon Receptor is an Environmental Sensor, Physiological Regulator and a Therapeutic Target in Ocular DiseaseChristine L Hammond, Elisa Roztocil, Vardaan Gupta, et al.
Investigative Ophthalmology & Visual Science|January 31, 2003
Sweep visual evoked potential evaluation of contrast sensitivity in Alzheimer's dementiaRobert W Crow, Lori B Levin, Laurie LaBree, et al.
Investigative Ophthalmology & Visual Science|November 19, 2024
Tapinarof, an Aryl Hydrocarbon Receptor Ligand, Mitigates Fibroblast Activation in Thyroid Eye Disease: Implications for Novel TherapyCharkira C Patrick, Elisa Roztocil, Farha Husain, et al.
Experimental Eye Research|March 23, 2026
Metformin inhibits PDGFβ signaling to suppress hyaluronan and cytokine production in thyroid eye diseaseFarha Husain, Charkira C Patrick, Elisa Roztocil, et al.
Thyroid : Official Journal of the American Thyroid Association|April 21, 2025
Targeting the Aryl Hydrocarbon Receptor to Attenuate IGF1R Signaling in Thyroid Eye DiseaseElisa Roztocil, Farha Husain, Charkira C Patrick, et al.
Investigative Ophthalmology & Visual Science|September 4, 2015
Retinal and Choroidal Folds in PapilledemaPatrick A Sibony, Mark J Kupersmith, Steven E Feldon, et al.
The Journal of Biological Chemistry|December 25, 2014
Salinomycin and other polyether ionophores are a new class of antiscarring agentCollynn F Woeller, Charles W O'Loughlin, Elisa Roztocil, et al.
Plos One|September 20, 2019
Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptorChristine L Hammond, Elisa Roztocil, Richard P Phipps, et al.
Pageof 7